Guangyao Kong

2.9k citations
74 papers · 2.1k indexed · h-index 26
Topics
Acute Myeloid Leukemia Research (16 papers)Hepatitis B Virus Studies (10 papers)Epigenetics and DNA Methylation (9 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Guangyao Kong

71 papers receiving 2.1k citations

Peers

Guangyao Kong
Comparison fields: 5 of 101
  • Molecular Biology 1.3k
  • Cancer Research 800
  • Epidemiology 418
  • Immunology 327
  • Hematology 224
Replace Patrick Anglard with:
Patrick Anglard France
Maj Hedtjärn Sweden
Oxana Bereshchenko Italy
Miguel Alejandro Lopez‐Ramirez United States
Carolina De La Torre Germany
Hiroyuki Kato Japan
Riccardo Taulli Italy
Kazuhiko Aoyagi Japan
Tetsuya Taga Japan
Jueng Soo You South Korea
Guangyao Kong relative to Patrick Anglard France Patrick Anglard's profile →
Citations per field
00.5×5.6×
Patrick Anglard · 1×
Citations per year

Countries citing papers authored by Guangyao Kong

Since Specialization
Citations

This map shows the geographic impact of Guangyao Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyao Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyao Kong more than expected).

Fields of papers citing papers by Guangyao Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyao Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyao Kong. The network helps show where Guangyao Kong may publish in the future.

Co-authorship network of co-authors of Guangyao Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyao Kong. A scholar is included among the top collaborators of Guangyao Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyao Kong. Guangyao Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 23
5 17
6 1
7 7
8 15
9 1
10 14
11 8
12 2
13 15
14 38
15 48
16 42
17 11
18 310
19 94
20 25

About Guangyao Kong

Guangyao Kong is a scholar working on Hematology, Hepatology and Biological Psychiatry, having authored 74 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Hepatitis B Virus Studies (10 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Cancer Research (800 citations), Hepatology (189 citations) and Hematology (224 citations). Guangyao Kong has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiaodong Zhang, Lihong Ye, Shuai Zhang, Yumei Du, Xiaona You, Changliang Shan, Yuen Gao, Junping Zhang, Tao Zhang and Erik A. Ranheim. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026